Quantcast

Latest Lundbeck Stories

2011-05-11 06:00:00

EVANSTON, Ill., May 11, 2011 /PRNewswire/ -- Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners. Druid BioVentures, Genesys Capital, PathoCapital, Lundbeck, Takeda Ventures, Inc. and Shire also participated in the round. Naurex will use the proceeds from the Series A financing primarily for...

2011-02-24 06:27:00

NEW YORK, Feb. 24, 2011 /PRNewswire/ -- Get content from Lundbeck at: http://www.thenewsmarket.com/Releases/StoryDetailPage.aspx?GUID=aa3126b8-011d-4687-90e0-fad014366811 Full year revenue was DKK 14,765 million and increased 7% compared to 2009, driven by a positive development in all regions. Profit from operations (EBIT) was DKK 3,357 million, increasing 17% and corresponding to an EBIT margin of 22.7% for the year. Products Cipralex®, Ebixa® and...

2011-01-12 08:52:00

PARSIPPANY, N.J., Jan. 12, 2011 /PRNewswire/ -- In 2011, what will be the major trends in the pharmaceutical industry? What will drive innovation? How will government regulations affect what's next and what's new? What will the game changers be? Who will survive in the competitive corporate landscape? When it comes to market research, what's the smartest and most effective way to get the job done right? The answers to these questions and much more will be revealed at a pivotal,...

2010-12-21 16:02:00

Ian Read, President and Chief Executive Officer, Pfizer Jerzy Gruhn, President, Novo Nordisk Inc. Mark Iwicki, President and Chief Operating Officer, Sunovion Pharmaceuticals Inc. Staffan Schuberg, President, Lundbeck Inc. WASHINGTON, Dec. 21, 2010 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced the election of four new members to its Board of Directors. "We are pleased to welcome four new biopharmaceutical heavyweights to join...

2010-12-16 01:00:00

LA JOLLA, Calif., Dec. 16, 2010 /PRNewswire/ -- Zenobia Therapeutics, Inc. (Zenobia) the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S (Lundbeck) utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery...

2010-11-03 04:22:00

NEW YORK, Nov. 3, 2010 /PRNewswire/ -- See video from Lundbeck at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=0c5e745c-050d-4fe3-8da5-8edbb8bc6db1&bhcp=1&alertid=d0b158ec-152f-49a0-a5a9-4a7a40807750# Danish-based H. Lundbeck A/S, a pharmaceutical company specialized in central nervous system (CNS) disorders, reports third quarter revenue of DKK 3,619 million, an increase of 7% compared to the third quarter results of 2009. Profit from operations (EBIT) was DKK...

2010-11-02 11:01:00

Coalition Welcomes the LEGO Group and Lundbeck to its Ranks WASHINGTON, Nov. 2, 2010 /PRNewswire-USNewswire/ -- The Coalition Against Domain Name Abuse (CADNA) welcomes its two newest members, LEGO Juris A/S and H. Lundbeck A/S. The LEGO Group manufactures the perennial childhood classic toy, LEGO® building blocks. Lundbeck is a global pharmaceutical company dedicated to researching and producing preparations against depression, as well as pharmaceuticals to treat central...

2010-09-21 05:00:00

SANTA MONICA, Calif., Sept. 21 /PRNewswire/ -- Reprints Desk, Inc. today announced that the company will highlight the ePrints NRx scientific literature licensing and deployment service during its exhibit at the 2nd Annual DigiPharm Europe 2010 event from September 28 to October 1, 2010. The service enables peer-reviewed journal articles from multiple content sources to be licensed with similar terms, then digitally deployed in online portals, via physician detailing and eDetailing...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related